FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill

The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.

'Guru of Abs' DaShaun Johnson launches senior health initiative

Samson Health & Fitness Center in Stonecrest hosted a free F.I.T.T.ness Prescription Kickoff event this morning, led by local fitness coach DaShaun Johnson.

Running community honors Atlanta legend ahead of weekend marathon

Thousands of participants pounded the pavement in downtown Atlanta on Sunday for the annual Publix Atlanta Marathon Weekend held outside of Mercedes-Benz Stadium while also honoring a local running legend.

'Warming up' with Midtown’s Drenched Cycle Studio

"I felt like I was dancing," says Kellie James about discovering spinning. "So, that was the first thing that hooked me."

Wegovy daily pill Is here: How to get it and what it costs

Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss pill approved for adults with obesity or overweight.

This New Year’s Day... take a hike!

Georgia State Parks will host ranger-led First Day Hikes statewide on January 1, 2026.

Misunderstood illness leaves millions exhausted, with most cases undiagnosed

Chronic fatigue syndrome is a misunderstood illness that affects 3.3 million people in the US, with one in four confined to bed at some point.

Trump announces price cuts on Wegovy, Zepbound

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity treatments Zepbound and Wegovy. Here’s what we know.

4 in 10 Americans are obese, annual report finds: See the worst states

For the first time in over a decade, the number of states with rates of obesity at 35% or higher has dropped, according to a recent report.

Study reveals 1 quick thing kids can do to boost their test scores

New research suggests a nine-minute burst of high-intensity exercise can sharpen kids’ brain function and improve academic performance, particularly in reading.

Popular weight-loss drugs could increase risk of developing eye conditions, vision loss, research suggests

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition that can lead to sudden vision loss due to lack of blood flow.